AGP Executive Report
Last update: 10 hours agoKidney Care & Research: A new “Managed Healthcare Executive” series episode breaks down FSGS as a histologic pattern driven by podocyte injury across ages, with causes ranging from diabetes and obesity to infections and genetics. Regulators & Leadership: The EMA named a new Deputy Executive Director and a new Head of Veterinary Medicines, with added oversight of IT security. Public Health Preparedness: Delhi’s health minister ordered government hospitals to keep essential medicines available through the monsoon, avoid early OPD/dispensing closures, and report shortages fast. Infectious Disease Risk: Europe’s heatwaves are pushing up water-related infections, and experts urge simple beach-and-pool precautions. Clinical Innovation: Focused ultrasound may boost outcomes for borderline resectable and locally advanced pancreatic cancer when paired with FOLFIRINOX, with Phase II results pointing to a Phase III push. Blood Product Access: The FDA licensed Ezplaz freeze-dried plasma, aiming to expand transfusion options in settings where cold-chain frozen plasma is hard to use. Healthcare Policy & Access: UKHSA analysis warns 2026 could bring the highest heat-associated deaths on record. Pharma Business: Regeneron reported strong Q2 growth, led by Dupixent, Libtayo, and U.S. EYLEA HD sales. Pharma Trade: The UK-India free trade deal is expected to accelerate medtech and digital health collaboration. Safety & Compliance: Telangana seized 113 abortion kits from a wholesaler over missing purchase bills, warning about risks from unsupervised use.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.